Bio-Techne, Lisen Partner on MDx Products for Chinese Market

Feb 26, 2019

|

NEW YORK (GenomeWeb) – Bio-Techne today announced a strategic agreement with China's Lisen Imprinting Diagnostics Wuxi in the field of precision medicine.

Specifically, the partnership, Minneapolis-based Bio-Techne said, will accelerate the development of molecular diagnostics in the Chinese market. Financial and other terms of the agreement were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Bio-Techne, Lisen Partner on MDx Products for Chinese Market

To read the full story....

Breaking News

BARDA Awards $5.4M to Luminex for Expanded Respiratory Panel With Coronavirus Target

In Brief This Week: Thermo Fisher Scientific, Fluidigm, Veracyte, and More

Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test

BGI Genomics Gets CE Mark for Multiplexed SARS-CoV-2, Influenza Tests

Commercial Coronavirus Antibody Tests Show Wide Variation in Accuracy in New Study

Clear Labs Nanopore Sequencing Coronavirus Test Gets FDA Emergency Use Authorization

Featured White Papers

Moving from Non-Invasive Prenatal Screening to Prenatal Diagnostics: An Expert Panel Discussion

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

What's Popular?

BioReference Settles False Claims, Kickback Allegations for $11.5M

United Airlines Launches COVID-19 Testing Program for Travelers to Hawaii

UBS Downgrades Illumina to Neutral; Expresses Doubts About Grail Deal

Becton Dickinson Submits Premarket Approval Supplement to FDA for HPV Assay

FDA Grants Emergency Use Authorization for GK Pharmaceuticals Coronavirus Test

Sponsorships